IUPAC NAME-6-Methylideneandrosta-1,4-diene-3,17-dione[1]
MOLECULAR FORMULA-C20H24O2
MOLAR MASS-296.403 g/mol
Exemestane is indicated for the adjuvant treatment of postmenopausal women with estrogen-receptor positive early breast cancer who have received two to three years of tamoxifen and are switched to it for completion of a total of five consecutive years of adjuvant hormonal therapy
SWAPNROOP DRUGS & PHARMACEUTICALS is a high tech enterprise which engaged in Loan Licensing Manufacturing of Pharmaceutical Products and Pharmaceutical Raw Materials. We are working under the guideline of GMP regulation also certification of ISO9000/HACCP,offering hundreds of chemical products for global market based on our three national producing bases. winning a high reputation of global customer with our good credit efficiency work, good quality and after service.
View more >>
Basic Information
Business Type: Manufacturer,Trading Company,Distributor/Wholesaler
Product/Service (We Buy): 11 - 50 People
Ownership Type: Individual (Sole proprietorship)
Registered Capital: US$501 Thousand - US$1 Million
Year Established: 2000
Number of Employees: 11 - 50 People
Trade & Market
Main Markets: North America,Southeast Asia,Mid East,South America,Africa,Eastern Asia,Eastern Europe,Oceania,Western Europe
QA/QC: In House
Number of Production Lines: 4
Number of R&D Staff: 98
Number of QC Staff: 11 - 20 People
Total Annual Sales Volume: US$5 Million - US$10 Million
India
China 
